Medicine market in Russia ‘stable’ as GSK commits to keeping up supply

GlaxoSmithKline’s (GSK) will halt clinical trials in Russia but maintain the supply of essential medicines, following the Kremlin-backed invasion of Ukraine. The London-headquartered group has no manufacturing operations in Russia or Ukraine, while its supply chain and raw material access will be minimally impacted, according to Reuters. GSK follows Pfizer, who has pledged all its [...]